Danish Multinational Pharmaceutical Company To Distribute And Supply Health Commodities To Kenya

Denmark has pledged to support Kenya's efforts to improve the country's health outcomes.

A meeting between health Cabinet Secretary Mutahi Kagwe and Danish ambassador to Kenya Ole Thonke on Thursday resolved to evaluate various areas of collaboration aimed at augmenting the country's health sector, especially on primary healthcare.

According to Thonke, Denmark has already committed 2.4 billion shillings to support primary healthcare and equip level two and three facilities with requisite resources.

"We have an extra 1.2 billion shillings for the same level one facilities that will work with community health workers. It's a huge support for integrating level ones to the system, "added Thonke.

Speaking during the meeting, the health CS appreciated the support accorded to Kenya by Denmark, saying it has gone a long way in improving health outcomes in the country.

He said the support, which included Covid-19 vaccines donation, has helped the country implement a raft of measures that have significantly improved the delivery of essential health services.

The Health CS said Kenya is ready to support multinational pharmaceutical companies set up their regional production units in the country.

"We would be happy to encourage Danish companies to establish here and support them in all ways. We have structured the micro and macro environments to support this. For instance, we reduced taxes and payments for manufacturers to encourage them to set up," said CS.

The health CS appealed to the Danish government to consider introducing exchange programmes for Kenyan healthcare workers on speciality training.

During the meeting, a memorandum of understanding between Kenya and Novo Nordisk, a Danish multinational pharmaceutical company to distribute and supply health commodities, including support for changing diabetes in children initiative, was discussed.

The initiative that targets type one diabetes currently supports 3,000 children, up from 160 when the project kicked off ten years ago. According to Francis Njau, the company's business unit head, Eastern and Southern Africa, sustainable support of the programme and diabetics supplies remain key in addressing the challenges of non-communicable diseases.

The health CS urged Novo Nordisk pharmaceutical company to consider local manufacturing for some of its pharmaceutical products, saying the Covid-19 pandemic brought the need to diversify the production of essential products.

©Standard Gazette, 2021. Unauthorized use and/or duplication of this material without express and written permission from this site’s publisher is strictly prohibited. Excerpts and links may be used, provided that full and clear credit is given to Standard Gazette with appropriate and specific direction to the original content.
Leave A Reply

Your email address will not be published.

This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept Read More

Translate »
Share on Social Media